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Excess of saturated fatty acids in the diet has been associatedwith obesity, leading to systemic disruption of insulin signaling, glucose
intolerance, and inflammation. Macadamia oil administration has been shown to improve lipid profile in humans. We evaluated
the effect of macadamia oil supplementation on insulin sensitivity, inflammation, lipid profile, and adipocyte size in high-fat diet
(HF) induced obesity in mice. C57BL/6 male mice (8 weeks) were divided into four groups: (a) control diet (CD), (b) HF, (c)
CD supplemented with macadamia oil by gavage at 2 g/Kg of body weight, three times per week, for 12 weeks (CD + MO), and
(d) HF diet supplemented with macadamia oil (HF + MO). CD and HF mice were supplemented with water. HF mice showed
hypercholesterolemia and decreased insulin sensitivity as also previously shown. HF induced inflammation in adipose tissue and
peritoneal macrophages, as well as adipocyte hypertrophy. Macadamia oil supplementation attenuated hypertrophy of adipocytes
and inflammation in the adipose tissue and macrophages.
1. Introduction
The role of a diet with a higher content of unsaturated fatty
acids, in place or concomitant to a diet with high content
of lipids, has been appointed as an effective strategy to
control metabolic disorders [1]. Monounsaturated fatty acids
(MUFA) rich diet has been reported to decrease plasma
total cholesterol and LDL-cholesterol and increase HDL-
cholesterol levels [2–5]. Moreover, when saturated fatty acids
are replaced by MUFA in the diet of obese women, levels of
inflammatory markers decrease, including IL-6 and visfatin
in serum [6]. Macadamia nut oil is rich in monounsaturated
fatty acids, containing approximately 65% of oleic acid (C18:1)
and 18% palmitoleic acid (C16:1) of the total content of fatty
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acids [7]. Macadamia oil is the main source of palmitoleic
acid in the human diet. Some studies have shown that diet
rich in macadamia can improve the lipid profile [2, 8–10], but
to date there is no studies on the effect of supplementation of
macadamia oil on adipocyte hypertrophy and inflammation.
In 2008, Cao and colleagues [11] showed that mice defi-
cient in lipid chaperones aP2 and mal1 present increased
levels of palmitoleic acid in serum. Elevated levels of cir-
culating palmitoleic acid restored sensitivity of insulin in
liver and skeletalmuscle, hepatosteatosis, and hyperglycemia,
generated by high-fat diet. With this, the authors named this
fatty acid as a lipokine, since palmitoleic acid has a hormonal-
like effect [11].
The administration of high-fat diet in C57BL6 mice
induces metabolic perturbations similar to those observed in
humans. In fact, consumption of the high levels of saturated
fatty acids is associated with overweight, visceral obesity,
inflammation, dyslipidemia, and insulin resistance, in skele-
tal muscle, liver, and adipose tissue [12–17]. Saturated FFA
promotes inflammation by interaction with toll-like receptor
4 (TLR4), activating NF𝜅B, JNK, and AP-1 pathways [18, 19].
A low grade inflammation is established with increase
in plasma levels of IL-6, IL-1𝛽, prostaglandins, TNF-𝛼, and
leptin and decrease in the production and secretion of adi-
ponectin, IL-10, and IL-4 [20, 21]. The increase in local
inflammation is potentiated by the recruitment of macro-
phages to adipose tissue and polarization ofM2macrophages
(macrophages type 2) toM1macrophages (macrophages type
1) [16, 22, 23].
The aim of our study was to evaluate the effect of mac-
adamia oil supplementation, rich in MUFA (palmitoleic and
oleic acids), on adipose tissue and peritoneal macrophages
inflammation in mice fed a balanced diet or high-fat diet
rich in saturated fatty acids. We measured glucose uptake
(2-6 deoxyglucose uptake) and mRNA content of proteins
(GLUT-4; IRS-1) involved in insulin signaling in soleus
muscle.The contents of IL-10, IL-6, TNF-𝛼, and IL-1𝛽 in peri-
tonealmacrophages and adipose tissue were also determined.
The adipocyte size was also evaluated.
2. Materials and Methods
2.1. Animals. All experiments were performed according to
protocols approved by the Animal Care and Use Committee
of the Institute of Biomedical Sciences, University of Sa˜o
Paulo. C57BL/6 male mice (8 weeks old) were used in this
study. Animals were housed with light-dark cycle of 12-12 h
and temperature of 23 ± 2∘C. Animals were divided into
four groups: (a) control diet (CD), (b) high-fat diet (HFD),
(c) control diet supplemented with macadamia nut oil (Vital
Aˆtman, Uchoa, SP, Brazil) (CD + MO), and (d) high-fat
diet supplemented with macadamia oil (HF + MO). Control
groupswere run concomitantly.The oil composition is shown
in Table 1. During the first 4 weeks preceding the induction
of obesity by HFD, all groups were ad libitum fed a control
diet (76% carbohydrates, 9% fat, and 15% proteins). Similar
protocol has been used in our previous studies [24, 25]. CD
+ MO and HF + MO were supplemented by oral gavage
at 2 g per Kg of body weight, three times per week, during
Table 1: Fatty acid composition of macadamia oil.
Fatty acid %
C12:0 lauric acid 0.09
C14:0 myristic acid 0.82
C16:0 palmitic acid 8.45
C16:1n7 palmitoleic acid 19.11
C17:0 heptadecanoic acid 0.28
C16:2n4 9,12-hexadecadienoic acid 0.02
C16:3n4 6,9,12-hexadecatrienoic acid 0.06
C18:0 stearic acid 3.90
C18:1n9 oleic acid 56.35
C18:1n7 vaccenic acid 3.09
C18:2n6 linoleic acid (LA) 1.35
C18:3n3 linolenic acid (ALA) 0.12
C20:0 arachidic acid 2.79
C20:1n9 gondoic acid 2.18
C20:1n11 gadoleic acid 0.12
C22:0 behenic acid 0.75
C22:1n9 erucic acid 0.22
C22:5n3 eicosapentaenoic acid 0.30
SFA 16.08
MUFA 80.01
PUFA 1.83
PUFA n3 0.42
PUFA n6 1.35
n3/n6 0.31
SFA = saturated fatty acids, sum of C12:0, C14:0, C16:0, C17:0, C18:0, C20:0,
and C22:0; MUFA = monounsaturated fatty acids, sum of C16:1, C18:1n7,
C18:1n9, C20:1n9, C20:1n11, and C22:1n9; PUFA = polyunsaturated fatty
acids, sum of C16:3n4, C18:2n6, C18:3n3, and C22:5n3; PUFA n3 = sum of
C18:3n3 and C22:5n3; PUFA n6 = C18:2n6.
12 weeks. This dosage of oil was chosen based on previous
studies from our group using different oils with no signs of
hepatic toxicity [24]. CD and HF diet received water at the
same dose.
2.2. Serum Parameters Analysis. Serum triacylglycerol, total
cholesterol, LDL-cholesterol, and HDL-cholesterol were
determined by colorimetric assays (Labtest Diagnostics,
Lagoa Santa, MG, Brazil). Serum glucose and insulin were
measured using LABTEST colorimetric assay and radioim-
munoassay (Millipore, Billerica, MA, USA), respectively, as
described by Masi et al. (2012) [24]. The HOMA index was
determined by calculating fasting serum insulin (𝜇U/mL)
× fasting plasma glucose (mmol L−1)/22.5. Leptin and adi-
ponectin were measured using the protocol of the manufac-
turing R&D system.
2.3. GTT and ITT. Glucose tolerance test (GTT) and insulin
tolerance test (ITT) were carried out in all groups after 6 h
fasting at the end of the 10th and 11th weeks of treatment,
respectively.
Themethodologies used for GTT and ITTwere similar to
that described by Masi et al. (2012) [24].
2.4. Insulin Responsiveness in Incubated Soleus Muscle. Ani-
mals were euthanized on CO
2
chamber and soleus muscles
rapidly and carefully isolated and weighed (8–10mg). This
protocol was described in [24, 25].
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Table 2: Primer sequences of the genes studies for real-time PCR.
Primer name Forward Reverse
RPL-19 5-AGC CTG TGA CTG CCA TTC-3 5-ACC CTT CCT CTT CCC TAT GC-3
GLUT-4 5-CAT TCC CTG GTT CAT TGT GG-3 5-GAA GAC GTA AGG ACC CAT AGC-3
IRS-1 5-CTC AGT CCC AAC CAT AAC CAG-3 5-TCC AAA GGG CAC CGT ATT G-3
CPT-1 5-CCT CCG AAA AGC ACC AAA AC-3 5-GCT CCA GGG TTC AGA AAG TAC-3
PGC1-a 5-CAC CAA ACC CAC AGA AAA CAG-3 5-GGG TCA GAG GAA GAG ATA AAG TTG-3
Perilipin 5 5-CAT GAC TGA GGC TGA GCT AG-3 5-GAG TGT TCA TAG GCG AGA TGG-3
2.5. Haematoxylin and Eosin Staining. Adipose samples were
fixed in formalin and paraffin embedded. Sections were
prepared (5 𝜇M) using Leica EG1150H Machine. Haema-
toxylin and Eosin (H&E) staining was conducted using Leica
Autostainer XL and Leica CV5030. Sections were mounted
using DPX media (Fisher Scientific, Ireland) and analyzed
using Nikon 80i transmission light microscope.
2.6. Extraction of Fatty Acids from Gastrocnemius Muscle
and Gas Chromatographic Analysis. Gastrocnemius muscle
fragments (100mg) were subjected to lipid extraction. For
this, 0.5mL chloroform/methanol (2 : 1; v/v) was added to
100mg of gastrocnemius sample, well-vortexed and incu-
bated at room temperature for 5min. Additional volumes of
1.25mL chloroform and 1.25mL deionized H
2
O were then
added, and finally, following vigorous homogenization for
3min, samples were centrifuged at 1200 g for 5min, at room
temperature to obtain two phases: aqueous phase in the top
and organic phase in the bottom containing. The organic
phase was collected, dried, and suspended in isopropanol.
Triglyceride contentwas then determined in the homogenate.
After that, for fatty acid composition determination, gastroc-
nemius lipid extracts were dried using atmospheric N
2
for
evaporation of the solvent without fatty acid oxidation. The
fractions of neutral and polar lipids were separated from
these extracts by using a column chromatography. The polar
(phospholipids) and neutral (triglycerides) fractions were
methylated (for formation of methyl esters), using acetyl
chloride and methanol. The methyl esters were analyzed in
a gas chromatographer coupled to a flame ionizer detector
(FID) (Varian GC 3900). Fatty acid composition was then
determined by using standard mixtures of fatty acids with
known retention times (Supelco, 37 Components).
For the analysis of fatty acids, a programmed chromatog-
raphy was used with the characteristics described below. The
reading was initiated at 170∘C temperature for 1 minute and
then a ramp of 2.5∘C/min was employed to reach a final
temperature of 220∘C that was maintained for 5min. The
injector and detector were maintained at 250∘C. We used the
CP wax 52 CB column, with a 0.25mm thickness, internal
diameter of 0.25mm, and 30mm long, with hydrogen as the
carrier gas.
2.7. Analysis of Inflammatory Parameters
2.7.1. Adipokines Content Measurements. Mice were eutha-
nized onCO
2
chamber and retroperitoneal adipose tissuewas
rapidly collected. About 100mg of retroperitoneal adipose
tissue was used for the determination of TNF-𝛼, IL-6, and
IL-10 content. Adipose tissue was homogenized in RIPA
buffer (0.625% Nonidet P-40, 0.625% sodium deoxycholate,
6.25mM sodium phosphate, and 1mM ethylenediaminete-
traacetic acid at pH 7.4), containing 10 g/mL of a protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA).
Homogenates were centrifuged at 12.000 g for 10min at 4∘C,
supernatant was collected, and protein concentration was
determined using Bradford assay (Bio-Rad, Hercules, CA,
USA). Bovine serum albumin was used as protein standard.
Ex Vivo Adipose Tissue Culture. Retroperitoneal adipose
tissue explants (about 100mg)were cultured inDMEMsterile
medium (Gibco), containing 10% FBS, 2mM glutamine,
streptomycin, and penicillin for 24 h, at 37∘C and 5% CO
2
,
humidified air environment. Thereafter, medium culture was
collected and used for the determination of IL-1𝛽 and IL-10,
using ELISA assays (DuoSet kits, R&D System).
2.7.2. Peritoneal Macrophage Isolation and Culture. Cytokine
and nitric oxide (NO) production were evaluated in
macrophages obtained by washing the peritoneal cavity with
6mL RPMI culture medium (Gibco), containing 10% FBS
and 4mM glutamine. Macrophage-rich cultures (more than
90% of the cells were F4/80+) were obtained by incubating
peritoneal cells in 24-well polystyrene culture plates for 2 h at
37∘C in a 5%CO
2
, humidified air environment. Nonadherent
cells were removed by washing with RPMI. Adherent cells
were then incubated with 2.5 𝜇g/mL of LPS (E. coli, serotype
0111:B4, Sigma Chemical Company, USA) for 24 h [26].
Mediumwas collected for determination of IL-6, IL-10, IL-1B
and TNF-𝛼 by ELISA and nitrite content by Griess method
[27].
2.8. Quantitative RT-PCR. Total RNA from the gastrocne-
mius muscle was extracted with Trizol reagent (Invitrogen
Life Technologies, Grand Island, NY, USA), following the
method described by Chomczynski and Sacchi [28]. Reverse
transcription to cDNA was performed using the high-capac-
ity cDNA kit (Applied Biosystems, Foster, CA, USA). Gene
expression was evaluated by real-time PCR [29], using Rotor
Gene (Qiagen) and SYBR Green (Invitrogen Life Technolo-
gies) as fluorescent dye. Primer sequences are shown in
Table 2. Quantification of gene expression was carried out
using the RPL-19 gene as internal control, as previously
described [30].
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Table 3: Effect of high fat diet, with or without supplementation of macadamia oil, on obesity characteristics.
CD CD +MO HF HF + MO
Initial body weight (g) 24.26 ± 5.02 24.77 ± 3.37 24.2 ± 3.42 24.4 ± 4.41
Final body weight (g) 26.2 ± 1.99 26.82 ± 3.32 34.49 ± 6.96∗# 34.75 ± 4.96∗#
Liver weight (g) 1.17 ± 0.14 1.10 ± 0.23 1.33 ± 0.52 1.24 ± 0.26
Mesenteric adipose tissue weight (g) 0.32 ± 0.14 0.28 ± 0.12 0.55 ± 0.28∗# 0.52 ± 0.23∗#
Epididymal adipose tissue weight (g) 0.63 ± 0.14 0.73 ± 0.34 1.45 ± 0.60∗# 1.59 ± 0.70∗#
Retroperitoneal adipose tissue weight (g) 0.21 ± 0.06 0.24 ± 0.12 0.53 ± 0.22∗# 0.55 ± 0.17∗#
Adiposity index (g) 1.16 ± 0.24 1.25 ± 0.53 2.53 ± 1.01∗# 2.65 ± 1.01∗#
Brown adipose tissue weight (g) 0.104 ± 0.06 0.116 ± 0.03 0155 ± 0.06 0.128 ± 0.02
Values represent the means ± S.D. of the data obtained from analysis of 15 animals per group. ∗𝑃 < 0.001 versus CD; #𝑃 < 0.001 versus CD + MO.
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Figure 1: Effect of MO supplementation on adipose tissue histology. (a) Histological sections stained with H&E. (b) Area of adipocytes.
CD = group of animals maintained on control diet; HF = group of animals fed high-fat diet; CD + MO = group of animals fed control diet
supplemented with macadamia oil; HF + MO = group of animals fed high-fat diet supplemented with macadamia oil. The data are given as
the means ± S.D. ∗𝑃 < 0.05 (𝑛 = 6).
2.9. Statistical Analysis. Results are presented as mean ±
S.D. All groups were compared by using two-way ANOVA
followed by Bonferroni posttest. Significance level was set at
𝑃 < 0.05.
3. Result
3.1. Characterization of the Experimental Model
3.1.1. Body Composition. Mice fed high-fat diet showed
increased body weight gain, hypercholesterolemia, and insu-
lin resistance. These modifications were similar to those
observed in our previous studies [24, 25]. Animals fed the
high-fat diet (HF and HF + MO) for eight weeks showed
increased (by 2-fold) body weight gain and visceral adiposity
index as compared with CD and CD + MO (Table 3). The
weights of the liver and the brown adipose tissue depot were
not altered with diet or supplementation (Table 3). Although
the visceral adiposity index of mice fed high-fat diet (HF and
HF + MO) was greater than in animals that received control
diet (CD and CD + MO), the HF group had an increase
(by 1,62-fold) of adipocytes size compared to the control
diet (Figures 1(a) and 1(b)), with statistical difference not
evidenced in HF + MO group. No difference was evidenced
by diet or supplementation in LDL-c, NEFA, and glycerol
(data not shown). Moreover, the basal glycemia and𝐾itt were
increased in both groups treated with high-fat diet (data not
shown). Homa-IR index was increased in the HF group (by
3-fold) as compared to the other groups including the HF +
MO (Figure 2(a)). This result suggests a beneficial effect of
macadamia oil supplementation on insulin responsiveness in
the HF group.
The peripheral insulin resistance was confirmed by glu-
cose uptake in incubated soleus muscle (data not shown),
as also shown previously [24, 25]. In addition, both groups
treatedwith high-fat diet showed decrease inGLUT-4mRNA
expression (Figure 2(b)). The PGC-1, IRS-1, CPT-1 and Per-
ilipin 5 mRNA expression were not modulated in our treat-
ment. The HF group showed an increase in triacylglycerol
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Figure 2: Insulin sensitivity and triacylglycerol content in skeletal muscle after 12 weeks. (a) HOMA-IR: homeostatic model assessment of
insulin resistance; (b) GLUT-4 gene expression; (c) triacylglycerol content in gastrocnemius muscle. The data are given as the means ± S.D.
In all experiments the animals were previously fasted for 6 hours. CD = group of animals maintained on control diet; HF = group of animals
fed high-fat diet; CD +MO = group of animals fed control diet supplemented with macadamia oil; HF +MO = group of animals fed high-fat
diet supplemented with macadamia oil. A.U. = arbitrary unit. ∗𝑃 < 0.05; ∗∗𝑃 < 0.01 (𝑛 = 6).
content in gastrocnemius muscle, but this effect was blunted
in HF + MO (Figure 2(c)). The fatty acid composition in
neutral or polar lipid fractions remains unchanged regardless
of the diet given and MO supplementation (see Table 1 in
Supplementary Material available online at http://dx.doi.org/
10.1155/2014/870634).
3.2. Macadamia Oil Supplementation Attenuates High-Fat
Diet Induced Inflammation. The contents of the anti-inflam-
matory cytokine IL-10 were increased in the HF + MO
group (approximately 4,09-fold) (Figure 3(a)), while IL-1b
concentration in the medium of adipose tissue explants was
increased in the HF group (Figure 3(b)).
When stimulated with LPS, macrophages from all
groups showed increased IL-6 production (by 2.97-fold)
(Figure 4(d)), whereas IL-10 and NO production were ele-
vated in cells from the HF and CT + MO groups (2.39-
and 4.08-fold compared to base line, resp.) (Figures 4(a) and
4(e)). No effect of LPS stimulation was observed on TNF-𝛼
production by macrophages from all groups (Figure 4(c)).
Moreover, macrophages from the HF group showed an
increase (by 2,41-fold) of IL-1𝛽 production compared to
unstimulated cells whereas the supplementation with MO
abolished this elevation (Figure 4(d)). Similar results were
found in NO production. MO attenuated nitrate production
by LPS stimulation on macrophages from the HF group
(Figure 4(a)). The production of IL-10 was decreased in the
CT group compared to CT + MO and HF groups (by 1,88-
fold) (Figure 4(e)). TNF-𝛼 and IL-6 production remained
unchanged by diet or supplementation (Figures 4(c) and
4(d)).
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Figure 3: Inflammatory parameters in adipose tissue homogenate and adipose tissue explant incubation medium. IL10 content in adipose
tissue homogenate (a) and IL1-𝛽 in the adipose tissue explant incubationmedium, after 24 hoursmeasured by ELISA (b).The animals received
water or macadamia oil orally, 2 g/kg b.w., with or without association with a high-fat diet. CD = group of animals maintained on control
diet; HF = group of animals fed high-fat diet; CD + MO = group of animals fed control diet supplemented with macadamia oil; HF + MO =
group of animals fed high-fat diet supplemented with macadamia oil. The data are given as the means ± S.D. ∗𝑃 < 0.05 (𝑛 = 5-6).
No significant difference was found in serum levels of
adiponectin after 12 weeks of treatment (data not shown). As
expected, leptin concentration was increased (by 5.69-fold)
in the groups fed the high-fat diet (data not shown). The sig-
nificant difference between the CD + MO and the CD + CT
groups suggests that MO can enhance circulant leptin.
4. Discussion
We showed herein that twelve weeks of macadamia oil sup-
plementation attenuate the increase in inflammation and
adipocyte hypertrophy in mice fed a high-fat diet that exhibit
signs of the metabolic syndrome.
High consumption of fat, sucrose, and industrialized
foods in association with sedentary lifestyle is the main con-
tributor to obesity and its related comorbidities, including
dyslipidemias, insulin resistance, and cardiovascular diseases;
evidence has been accumulated that low grade inflammation
plays a key role in the obesity induced comorbidities [11, 31–
37].
The increase in adipocytes size was attenuated by macad-
amia oil treatment. The increase in adipocyte diameter has
been associated with disturbances in cellular homeostasis,
such as insulin resistance, inflammation, and hypoxia [38].
The prevalence of large adipocytes increases leptin produc-
tion and secretion, as observed in our study [39].The increase
in leptin is associated with an elevation in low grade inflam-
mation. Leptin is known to stimulate proinflammatory cytok-
ines production in lymphocytes [40–42], monocytes [43],
and macrophages [44].
Mice fed the HFD for 8 weeks exhibited increased IL-10
content in retroperitoneal adipose tissue. This result may
be associated with the increase in peroxisome proliferator
activated receptor- (PPAR-) gamma activity. This nuclear
receptor increased the number of small adipocytes and
raised the IL-10 [45, 46]. The increase of IL-10 content in
adipose tissue leads to macrophage polarization (type 2)
that is important for remodeling and tissue repair [47, 48].
Moreover, the increase in IL-10 content in adipocytes is
associated with increased insulin sensitivity in adipose tissue
[49, 50].
IL-1𝛽 strongly induces the inflammatory response in
innate immune cells [51], via JNK andNF𝜅Bpathway [52]. IL-
1𝛽 is also a potent inductor of insulin resistance.This cytokine
decreased insulin-stimulated glucose uptake via ERK activa-
tion [53]. Patients with high level of the circulating IL-1𝛽 are
associatedwith greater risk on development of type 2 diabetes
[54]. Adipose tissue and peritoneal macrophages are two
sources of IL-1𝛽, and macadamia oil supplementation was
effective in decreasing the production of this cytokine in both.
However, unexpectedly, the CDM showed an increased IL-1𝛽
production after LPS stimulation in peritoneal macrophages.
NO production is increased in LPS-stimulated macro-
phages beingmore pronounced inmice fed high-fat diet [24].
We demonstrated herein that the same pattern and the sup-
plementation with macadamia oil prevented the production
of NO by peritoneal macrophages from HF mice. Other
bioactive compounds, such as epigallocatechin gallate and
resveratrol [55], decrease NO production by macrophage
inhibition through of MAP kinase, JNK, and NF𝜅B signaling
[56].
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Figure 4: Nitric oxide and cytokine production by peritoneal macrophages. Peritoneal macrophages were collected and cultured for 24 h
in the absence (white bars) or presence (black bars) of 2.5𝜇g/mL LPS. Nitric oxide (a), IL1-𝛽 (b), TNF-𝛼 (c), IL-6 (d), and IL-10 (e) were
measured. CD = control diet; HF = high-fat diet; CD + MO = control diet + macadamia oil; HF + MO = high-fat diet + macadamia oil. The
data are given as the means ± S.D. ∗𝑃 < 0.05; ∗∗∗𝑃 < 0.001 (𝑛 = 5-6).
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In conclusion, macadamia oil supplementation attenu-
ated inflammation and adipocyte hypertrophy in obese mice.
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